Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to $230209.0.

  • BioRestorative Therapies' Change in Account Payables rose 2412.93% to $230209.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $438760.0, marking a year-over-year increase of 15212.61%. This contributed to the annual value of $293680.0 for FY2024, which is 148857.58% up from last year.
  • As of Q3 2025, BioRestorative Therapies' Change in Account Payables stood at $230209.0, which was up 2412.93% from $10430.0 recorded in Q2 2025.
  • Over the past 5 years, BioRestorative Therapies' Change in Account Payables peaked at $230209.0 during Q3 2025, and registered a low of -$297599.0 during Q4 2022.
  • For the 5-year period, BioRestorative Therapies' Change in Account Payables averaged around $37962.5, with its median value being $41513.0 (2024).
  • Per our database at Business Quant, BioRestorative Therapies' Change in Account Payables crashed by 36258.79% in 2021 and then surged by 48087.4% in 2024.
  • BioRestorative Therapies' Change in Account Payables (Quarter) stood at -$73731.0 in 2021, then tumbled by 303.63% to -$297599.0 in 2022, then surged by 87.24% to -$37966.0 in 2023, then surged by 315.17% to $81690.0 in 2024, then surged by 181.81% to $230209.0 in 2025.
  • Its last three reported values are $230209.0 in Q3 2025, $10430.0 for Q2 2025, and $116431.0 during Q1 2025.